Resistance to antiplatelet drugs: molecular mechanisms and laboratory detection
Author:
Open Access
- 9 July 2007
- journal article
- review article
- Published by Elsevier in Journal of Thrombosis and Haemostasis
- Vol. 5, 230-237
Abstract
No abstract availableKeywords
This publication has 75 references indexed in Scilit:
- Aspirin resistance detected with aggregometry cannot be explained by cyclooxygenase activity: involvement of other signaling pathway(s) in cardiovascular events of aspirin‐treated patientsJournal of Thrombosis and Haemostasis, 2006
- Determination of Clopidogrel Resistance by Whole Blood Platelet Aggregometry and Inhibitors of the P2Y12 ReceptorClinical Chemistry, 2006
- Aspirin resistanceThe Lancet, 2006
- Platelet function analyzer (PFA)‐100® closure time in the evaluation of platelet disorders and platelet functionJournal of Thrombosis and Haemostasis, 2006
- Monitoring of Clopidogrel Action: Comparison of MethodsClinical Chemistry, 2005
- Variability in response to aspirin: do we understand the clinical relevance?Journal of Thrombosis and Haemostasis, 2005
- Aspirin and ClopidogrelArteriosclerosis, Thrombosis, and Vascular Biology, 2004
- Clopidogrel resistanceCatheterization and Cardiovascular Interventions, 2004
- Aspirin resistance: definition, mechanisms and clinical read-outsJournal of Thrombosis and Haemostasis, 2003
- Platelet function analyzer (PFA-100): A tool to quantify congenital or acquired platelet dysfunctionJournal of Laboratory and Clinical Medicine, 2001